Defunct Company
Total Trials
10
As Lead Sponsor
As Collaborator
0
Total Enrollment
2,959
NCT00802425
Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 2008
Completion: Oct 31, 2012
NCT00860808
Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus
Start: Mar 31, 2009
Completion: Aug 31, 2011
NCT01270282
Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus
Start: Feb 28, 2011
Completion: May 31, 2013
NCT02040194
AM-101 in the Treatment of Acute Tinnitus 3
Phase: Phase 3
Start: Jan 31, 2014
Completion: Dec 28, 2017
NCT01803646
AM-101 in the Treatment of Acute Tinnitus 2
Start: Feb 28, 2014
Completion: Jun 30, 2016
NCT01934010
AM-101 in the Treatment of Post-Acute Tinnitus 1
Start: Jun 30, 2014
Completion: Jan 31, 2017
NCT02040207
AM-101 in the Treatment of Post-Acute Tinnitus 2
Completion: Dec 31, 2016
NCT02561091
AM-111 in the Treatment of Acute Inner Ear Hearing Loss
Start: Nov 30, 2015
Completion: Sep 30, 2017
NCT02809118
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Start: Jun 30, 2016
Completion: Feb 28, 2018
NCT03908567
AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery
Start: Jul 18, 2019
Completion: Mar 28, 2022